Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in... see more

Recent & Breaking News (NDAQ:BMRA)

Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter

GlobeNewswire January 15, 2020

Houston Methodist (part of Texas Medical Center) to start patient enrollment for Biomerica's InFoods® Irritable Bowel Syndrome (IBS) diagnostic guided therapy clinical trial

GlobeNewswire January 7, 2020

Biomerica Reports 1st Quarter Fiscal 2020 Financials

GlobeNewswire October 16, 2019

Biomerica Announces Fiscal Year End 2019 Financial Results

GlobeNewswire August 30, 2019

Republic of Colombia's food and drug regulatory agency grants clearance for Biomerica's colorectal cancer screening test to be sold in Colombia

GlobeNewswire August 21, 2019

Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.

GlobeNewswire June 5, 2019

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS)

GlobeNewswire April 8, 2019

LD Micro Virtual Conference Is Live, March 12th and 13th

Accesswire March 12, 2019

Biomerica Announces Updates for H. Pylori Clinical Studies

GlobeNewswire February 5, 2019

Biomerica Announces Second Quarter Financial Results

GlobeNewswire January 15, 2019

Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer

GlobeNewswire November 28, 2018

Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications

GlobeNewswire November 16, 2018

Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud

GlobeNewswire November 7, 2018

Biomerica Reports 1st Quarter Fiscal 2019 Financials

GlobeNewswire October 16, 2018

Biomerica Announces Fiscal Year End 2018 Financial Results

GlobeNewswire August 30, 2018

Biomerica Receives Notice of Allowance for Irritable Bowel Syndrome (IBS) Test Panel and Methods in Korea

GlobeNewswire August 2, 2018

Biomerica Announces First Patient Enrollment in Clinical Study for New Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy

GlobeNewswire June 25, 2018

Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board

GlobeNewswire April 19, 2018

Biomerica Announces Third Quarter Financial Results

GlobeNewswire April 17, 2018

Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer

GlobeNewswire March 8, 2018